Beaconcure Inc., a leader in AI-enabled clinical data validation and automation, announces a strategic partnership with Phastar Inc., a global specialist biometrics contract research organization (CRO), to enhance clinical review processes in clinical trials. This partnership combines Beaconcure’s advanced technology with Phastar’s extensive experience and vision in the clinical data analytics domain, to streamline clinical trial development and accelerate the delivery of lifesaving drugs.
Ilan Carmeli, Chief Operating Officer and Co-founder at Beaconcure, expressed his enthusiasm about the partnership, stating, “We are thrilled to collaborate with Phastar, a leader in clinical trial analytics. By leveraging Verify, Phastar is now equipped with a collaboration platform that reduces the potential for human error and increases efficiency and transparency, enabling faster study validation and approvals. By utilizing a unified platform, teams can integrate efforts, improve data integrity, and accelerate decision-making. These enhancements enable Phastar to manage internal communications and sponsor interactions more effectively, transforming clinical reviews, shortening review cycles, and expediting the delivery of treatments.”
Also Read: Clarify Health Recognized as a Leader in G2’s Healthcare Analytics Software Category
Ping-Chung Chang, Head of Business Transformation and China General Manager at Phastar, highlighted the importance of the partnership: “We at Phastar prioritize our customers’ needs and continuously seek innovative solutions to ensure timely access to lifesaving treatments for patients with urgent needs. Integrating Beaconcure’s Verify platform into our processes is an impactful step and will help unlock further innovations across clinical data reporting, reviewing, and submission stages. We will utilize Verify to address critical areas in clinical review with automatically generated audit trails, streamlined data reporting delivery, and optimized workflow management.”
Beaconcure is committed to continuous innovation and being at the forefront of developing technological advancements that transform clinical research. “Through this partnership, Beaconcure and Phastar are actively engaged in exploring new standards in the industry to increase speed and compliance in clinical trials,” says Christine Oliver, Chief Executive Officer at Beaconcure. “By partnering with Phastar and drawing on Mr. Chang’s expertise, we’re not just deploying solutions—we’re creating a dynamic system that learns and improves over time.”
SOURCE: Businesswire